1443-42-1 Usage
General Description
(4-Methylpyridin-3-yl)methylamine is a chemical compound with the molecular formula C8H11N. It is an organic amine with a methylpyridine group, commonly used as a building block in the synthesis of various pharmaceutical and agrochemical products. (4-METHYLPYRIDIN-3-YL)METHYLAMINE is known for its ability to act as a ligand in the coordination of transition metals, and it is also used in the production of various organic intermediates. Additionally, (4-Methylpyridin-3-yl)methylamine has potential applications in the field of medicinal chemistry and drug discovery, and it is also used in the synthesis of various heterocyclic compounds. Overall, this chemical compound has a wide range of uses and applications in the fields of chemistry and pharmaceuticals.
Check Digit Verification of cas no
The CAS Registry Mumber 1443-42-1 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,4,4 and 3 respectively; the second part has 2 digits, 4 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1443-42:
(6*1)+(5*4)+(4*4)+(3*3)+(2*4)+(1*2)=61
61 % 10 = 1
So 1443-42-1 is a valid CAS Registry Number.
InChI:InChI=1/C7H10N2/c1-6-2-3-9-5-7(6)4-8/h2-3,5H,4,8H2,1H3
1443-42-1Relevant articles and documents
-
Schmitz,Schunack
, p. 433,436 (1975)
-
HETEROCYCLIC COMPOUND AND USE THEREOF
-
Page/Page column 66, (2021/04/02)
Provided is a heterocyclic compound that can have an antagonistic action on an NMD A receptor containing the NR2B subunit and that is expected to be useful as a prophylactic or therapeutic agent for depression, bipolar disorder, migraine, pain, peripheral symptoms of dementia and the like. A compound represented by the formula (I), wherein each symbol is as defined in the DESCRIPTION, or a salt thereof.
7-Substituted Purine Derivatives for Immunosuppression
-
Page/Page column 11, (2008/12/05)
The present invention provides novel purinone and related derivatives useful for the prevention and treatment of autoimmune diseases, inflammatory disease, mast cell mediated disease and transplant rejection. The compounds are of the general formula III:
